21 related articles for article (PubMed ID: 17008071)
1. Artificial Intelligence in Digital Pathology for Bladder Cancer: Hype or Hope? A Systematic Review.
Khoraminia F; Fuster S; Kanwal N; Olislagers M; Engan K; van Leenders GJLH; Stubbs AP; Akram F; Zuiverloon TCM
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760487
[TBL] [Abstract][Full Text] [Related]
2. Neurofuzzy modeling to determine recurrence risk following radical cystectomy for nonmetastatic urothelial carcinoma of the bladder.
Catto JW; Abbod MF; Linkens DA; Larré S; Rosario DJ; Hamdy FC
Clin Cancer Res; 2009 May; 15(9):3150-5. PubMed ID: 19336522
[TBL] [Abstract][Full Text] [Related]
3. A computer-based diagnostic and prognostic system for assessing urinary bladder tumour grade and predicting cancer recurrence.
Spyridonos P; Cavouras D; Ravazoula P; Nikiforidis G
Med Inform Internet Med; 2002 Jun; 27(2):111-22. PubMed ID: 12507270
[TBL] [Abstract][Full Text] [Related]
4. [Cancer of the urinary bladder: prognosis of the outcome].
Zimichev AA; Prianichnikova MB; Maklakov VN
Urologiia; 2009; (3):52-3. PubMed ID: 19673123
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
6. Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma.
Hutterer GC; Karakiewicz PI; Zippe C; Lüdecke G; Boman H; Sanchez-Carbayo M; Casella R; Mian C; Friedrich MG; Eissa S; Akaza H; Serretta V; Hedelin H; Rupesh R; Miyanaga N; Sagalowsky AI; Perrotte P; Lotan Y; Marberger MJ; Shariat SF
BJU Int; 2008 Mar; 101(5):561-5. PubMed ID: 18257856
[TBL] [Abstract][Full Text] [Related]
7. Development of biomarker classifiers from high-dimensional data.
Baek S; Tsai CA; Chen JJ
Brief Bioinform; 2009 Sep; 10(5):537-46. PubMed ID: 19346320
[TBL] [Abstract][Full Text] [Related]
8. [Bladder tumors].
Le Duc A
Rev Prat; 1999 Jan; 49(2):191-4. PubMed ID: 9989157
[No Abstract] [Full Text] [Related]
9. Cell-nuclear data reduction and prognostic model selection in bladder tumor recurrence.
Tasoulis DK; Spyridonos P; Pavlidis NG; Plagianakos VP; Ravazoula P; Nikiforidis G; Vrahatis MN
Artif Intell Med; 2006 Nov; 38(3):291-303. PubMed ID: 17008071
[TBL] [Abstract][Full Text] [Related]
10. Nomograms for bladder cancer.
Shariat SF; Margulis V; Lotan Y; Montorsi F; Karakiewicz PI
Eur Urol; 2008 Jul; 54(1):41-53. PubMed ID: 18207314
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
